Patheon IncTSX: PTI

Patheon Inc. to present at the UBS Global Life Sciences Conference

· Issued by Patheon Inc via CNW
TORONTO, Sept. 23 /CNW/ - Patheon Inc. (TSX: PTI) today announced that
the Company will present at the UBS Global Life Sciences Conference on
Tuesday, September 27, 2005 at 3:30 p.m. (Eastern Time). The conference is
being held at The Grand Hyatt, in New York City, New York.
All interested parties are invited to listen to the live audio webcast of
the presentation by Robert C. Tedford, Chief Executive Officer, Patheon Inc.,
via Patheon's website at www.patheon.com, or through the UBS website, at the
following link: http://event.streamx.us/event/20050926 (Microsoft Media Player
or RealPlayer required). The webcast will include audio only.
An archived replay of the webcast presentation will be available on the
UBS website until October 29, 2005, and also will be accessible via the
Patheon website.

Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. With the addition of its wholly owned subsidiary MOVA Pharmaceutical
Corporation, acquired in December 2004, Patheon operates a network of 14
facilities in the United States, Canada and Europe, employing more than 5,900
people and serving a client base of 180 pharmaceutical and biotechnology
companies.
%SEDAR: 00001700E

Patheon Inc on 6ix

In the deck

Earlier from Patheon

Later from Patheon

All Patheon news releases